Detalles de la búsqueda
1.
A double-blind, randomized, multicenter, controlled study to evaluate the immunogenicity, safety, and tolerability of varicella vaccine (VARIVAX™) passage extension 34 (PE34) process administered concomitantly with measles, mumps, and rubella vaccine (M-M-R™ II).
Hum Vaccin Immunother;
16(11): 2634-2640, 2020 11 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-32429738
2.
Immunogenicity and Safety of a Measles-Mumps-Rubella Vaccine Administered as a First Dose to Children Aged 12 to 15 Months: A Phase III, Randomized, Noninferiority, Lot-to-Lot Consistency Study.
J Pediatric Infect Dis Soc;
9(2): 194-201, 2020 Apr 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-30849175
3.
Lot-to-lot consistency, safety and immunogenicity of 3 lots of Haemophilus influenzae type b conjugate vaccine: results from a phase III randomized, multicenter study in infants.
Vaccine;
35(28): 3564-3574, 2017 06 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-28536030
4.
Safety of a quadrivalent meningococcal serogroups A, C, W and Y conjugate vaccine (MenACWY-CRM) administered with routine infant vaccinations: results of an open-label, randomized, phase 3b controlled study in healthy infants.
Vaccine;
32(8): 965-72, 2014 Feb 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-24397906
5.
Coadministration of RIX4414 oral human rotavirus vaccine does not impact the immune response to antigens contained in routine infant vaccines in the United States.
Pediatrics;
122(5): e1062-6, 2008 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-18977955
6.
A combination measles, mumps, rubella, and varicella vaccine (ProQuad) given to 4- to 6-year-old healthy children vaccinated previously with M-M-RII and Varivax.
Pediatrics;
117(2): 265-72, 2006 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-16452343
Resultados
1 -
6
de 6
1
Próxima >
>>